Merck
Trade Merck 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRK
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other.
MRK Key Statistics
Stock Snapshot
Merck(MRK) stock is priced at $152.77, giving the company a market capitalization of 375.58B. It carries a P/E multiple of 108.04 and pays a dividend yield of 2.49%.
During the trading session on 2026-08-19, Merck(MRK) shares reached a daily high of $154.50 and a low of $141.80. At a current price of $152.77, the stock is +7.7% higher than the low and still -1.1% under the high.
Trading activity shows a volume of 32.54M, compared to an average daily volume of 8.22M.
The stock's 52-week range extends from a low of $77.58 to a high of $154.50.
The stock's 52-week range extends from a low of $77.58 to a high of $154.50.
MRK News
Morgan Stanley upgraded Merck (MRK) to Overweight from Equal Weight with a price target of $179, up from $116. The recent success for Merck pipeline cancer drug...
...
The stocks of five of the world’s largest drugmakers are on track for a record close. AbbVie’s shares ABBV were up 2.6% on Wednesday, while Amgen AMGN gained 3...
Analyst ratings
68%
of 31 ratingsMore MRK News
Which Drugmaker Stock Has Dominated in 2026: Merck, Pfizer, or Amgen? By David Moadel Published Aug 19, 3:20PM EDT Quick Read Merck surged 44% YTD, topping Am...
Add Decrypt as your preferred source to see more of our stories on Google. In brief Moderna (MRNA) jumped ~131% Wednesday after the Phase 3 INTerpath-001 trial...
A late-stage trial that combined a messenger ribonucleic acid (mRNA) shot jointly developed by Moderna (MRNA +129.65%) and Merck with Merck’s Keytruda yielded s...
Moderna, Merck Score Melanoma Cancer Breakthrough Wednesday, Moderna (MRNA) exploded, soaring more than 100% after the company released positive topline result...
Eli Lilly, Novo Nordisk and Merck: Buy, Sell or Hold? By Vandita Jadeja Published Aug 19, 12:00PM EDT Quick Read LLY dominates the GLP-1 race with 48% revenue...
Leerink notes Merck (MRK) and Moderna (MRNA) announced the top-line recurrence-free survival and distant metastasis-free survival success of the Phase 3 INTerpa...
Pfizer (PFE) stock was up 3.74% on Wednesday, despite a lack of news from the biopharmaceutical company. However, that doesn’t mean that PFE stock was up withou...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.